Young women who survived a myocardial infarction may have nearly double the risk of rehospitalization in the year after discharge compared to men, according to a new study.
All News
Advertisement
Advertisement
Your daily dose of clinical news you may have missed.
The novel vaccine, from biopharma company GSK, is approved to prevent RSV-associated lower respiratory tract disease in adults aged ≥60 years.
The American College of Physicians announced an initiative that renews and expands its focus on equitable access to obesity care, including new resources for physicians.
Experts in diabetic nephropathy present a study of the use of the KidneyIntelX test in patients with DKD.
Experts review the role of the urinary albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) in current DKD progression screening practices.
The updated American College of Physicians osteoporosis treatment guideline is summarized in this topline review for primary care clinicians.
In a study of over 1000 children and adolescents, authors identified 4 distinct profiles of psychiatric comorbidity with differing risk for a self-harm event.
Your daily dose of clinical news you may have missed.
Infants with neonatal opioid withdrawal syndrome cared for using a novel functional approach were discharged nearly 7 days sooner than those treated with usual care.
Advertisement
One in 5 US adults without access to transportation skipped medical care last year, with racial/ethnic minorities at greatest risk, study finds.
A combination of outreach measures tailored to the needs of rural Midwest women increased recommended screenings by as much as 6-fold.
Researchers found that reliable improvement of depressive symptoms after psychological therapy was associated with a 12% decrease in CVD risk at any given time.
Your daily dose of clinical news you may have missed.
The US health care provider community continues to do its collective best to cope with the protean condition that is long COVID, according to recent poll findings.
Persons with long COVID showed compensatory neural activity in certain brain areas while performing memory tasks as long as 6 months after infection resolved.
Your daily dose of clinical news you may have missed.
Vowst is the first and only FDA-approved orally administered microbiota-based therapeutic for the prevention of recurrent C. diff infection in adults.
"Disconnect" on anticoagulation between MDs and patients; NASH resolves after bariatric surgery; antiobesity medications are not weight-loss drugs; plus 2 more updates of note.
Dubbed the "twincretin," the GLP-1/GIP RA met weight and HgbA1c reduction endpoints, with nearly half of tirzepatide-treated patients achieving weight loss of at least 15%.
Advertisement
Advertisement
Advertisement
